Indirect calorimetry-guided parenteral nutrition in adults with cancer
Official title: Comparing Measured Resting Energy Expenditure to Weight-Based Equations for Parenteral Nutrition Prescribing in Oncology Patients: A Randomized Trial
Run by Fox Chase Cancer Center · NCT07776704 · Data updated 2026-11-12
This study tests whether using indirect calorimetry to guide parenteral nutrition dosing is feasible and helps cancer patients who can’t meet nutrition needs by eating or tube feeding.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Fox Chase Cancer Center Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Status | Recruiting |
| Started | August 21, 2025 |
| Main results expected | July 2028 |
| Study ends | January 2029 |
| Registry record updated | August 20, 2026 |
| Trial ID | NCT07776704 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with cancer who require parenteral nutrition for at least one week and can communicate in English.
✕Probably not a fit
Patients not benefiting may include those with rapidly changing energy needs, organ failure, or conditions where calorimetry-guided dosing is not applicable.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-center, randomized, open-label pilot study enrolling 50 adults with cancer who require parenteral nutrition. Participants are assigned to either standard weight-based PN dosing or PN dosing guided by indirect calorimetry to measure energy needs. The study looks at feasibility, acceptability, changes in PN prescriptions, adverse events, quality of life, and survival to assess potential benefits and practical use in oncology care.
Why it matters
Potential benefit: If successful, patients may receive more accurate PN dosing leading to better nutrition and quality of life.
How similar studies have gone: Previous work in related areas suggests energy-based PN dosing can be feasible, but this approach in oncology PN is early-stage and pilot in nature.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged ≥18 years * Diagnosis of cancer * Requirement for PN ≥1 week * Ability to provide informed consent * English-speaking Exclusion Criteria: * Hospice enrollment * Mechanical ventilation * Chest tube or drain * Continuous renal replacement therapy * Supplemental oxygen
Where it's running
-
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Amino acid–only IDPN for adults on dialysis with malnutrition
This study looks back at medical records to see if giving a 7.2% amino acid solution during dialysis helps nutritional status in adults with chronic kidney disease on maintenance hemodialysis.
-
Immunonutrition and Brain Monitoring to See if Delirium Happens After Gynecologic Cancer Surgery
This study tests whether a preoperative immunonutrition scoring plus intraoperative brain monitoring can help predict or relate to postoperative delirium in women aged 65 and older undergoing major gynecologic cancer surgery.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.